FDAnews
www.fdanews.com/articles/84322-nasal-spray-pitched-for-brittle-bones

NASAL SPRAY PITCHED FOR BRITTLE BONES

February 3, 2006

A Washington state-based pharmaceutical company will let Procter & Gamble Co. develop and market its nasal spray for treatment of osteoporosis, the companies said Wednesday. Nastech Pharmaceutical Company Inc. of Bothell, Wash., said it will grant P&G rights to the worldwide development and commercialization of its parathyroid hormone nasal spray. Terms of the deal include a $10 million initial payment, with additional goal-based payments that could reach $577 million over the life of the agreement.
The Daily News Online